There are 802 resources available
802 - Safety and preliminary efficacy of nivolumab in patients with advanced hepatocellular carcinoma: interim analysis of the phase 1/2 CheckMate-040 study
Presenter: Ignacio Melero
Session: Gastrointestinal tumours
Resources:
Abstract
826 - Claudin 18.2 – a novel treatment target in the multicenter, randomized, phase II FAST study, a trial of epirubicin, oxaliplatin, and capecitabine (EOX) with or without the anti-CLDN18.2 antibody IMAB362 as 1st line therapy in advanced gastric and gastroesophageal junction (GEJ) cancer
Presenter: Florian Lordick
Session: Gastrointestinal tumours
Resources:
Abstract